Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for Recurrent or Progressive Childhood Ependymoma
NCT02155920Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2015
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in ependymoma, sponsored by UT Southwestern Medical Center. Started Feb 2015; status: completed.
02
Drugs
everolimus
03
Conditions
ependymoma
Beyond the preview
Go deeper on NCT02155920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02155920.